Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
Waddington, CS, Andrews, N, Hoschler, K, Walker, WT, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, PE, Allen, RJ, Okike, I, Ladhani, S, Sheasby, E, Waight, P, Collinson, AC, Heath, PT, Finn, A, Faust, SN, Snape, MD, Miller, E, Pollard, AJ
Published in Health technology assessment (Winchester, England) (01.10.2010)
Published in Health technology assessment (Winchester, England) (01.10.2010)
Get full text
Journal Article
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
Waddington, Cs, Andrews, N, Hoschler, K, Walker, Wt, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, Pe, Allen, Rj, Okike, I, Ladhani, S, Sheasby, E, Waight, P, Collinson, Ac, Heath, Pt, Finn, A, Faust, Sn, Snape, Md, Miller, E, Pollard, Aj
Published in Health technology assessment (Winchester, England) (01.10.2010)
Published in Health technology assessment (Winchester, England) (01.10.2010)
Get full text
Journal Article
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Waddington, Claire S, Walker, W T, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P E, Allen, R J, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A C, Heath, P T, Finn, A, Faust, S N, Snape, M D, Miller, E, Pollard, A J
Published in BMJ (27.05.2010)
Published in BMJ (27.05.2010)
Get full text
Journal Article